NOTICE: This page will be retired at the end of 2013, please add the login pages you use to your favourites.
ESSENTIAL KNOWLEDGE TO EMPOWER YOUR DRUG DISCOVERY AND DEVELOPMENT
Thomson Reuters IntegritySM provides researchers with reliable, detailed information, from the perspective of a scientist, across multiple disciplines to support successful drug research and development.
Updated daily, its expertly refined drug information is integrated in a single, flexible resource that can help to drive innovation and support earlier decision-making.
DYNAMIC, RELEVANT DRUG NEWS AND EMAIL ALERTS POSTED EVERY BUSINESS DAY
Every business day, Thomson Reuters Drug News selects the latest, most important drug discovery and development news, places it in context, and presents it online and as email alerts in a clear, concise format that makes it easy to discover the important facts at a glance.
Drug News contains an archive of news covering drug R&D since 1996, with chemical structure images.
Publishes original scientific articles dealing with the evaluation of methodologies and results obtained during the scientific assessment of drugs and biologics in animals and humans. [Archives]